Event Details
July 24, 2015
Description
The U.S. Food and Drug Administration (FDA) approved Praluent, a new cholesterol-lowering injectable drug.
Participants (1)
| Name | Type | Mentions | |
|---|---|---|---|
| Administration | organization | 376 | View Entity |
Source Documents (1)
HOUSE_OVERSIGHT_026362.jpg
This document is an email from Jeffrey Epstein to Sultan Bin Sulayem on July 24, 2015, discussing a new, expensive cholesterol-lowering drug called Praluent. Epstein's email is a reply to an inquiry from Sulayem, who had forwarded a Forbes article announcing the FDA's approval of the drug, which is administered as a shot.
Related Events
Events with shared participants
The Administration's proposal in the 2008 Budget to consolidate DOJ's grant programs.
2008-01-01
Opening of the Venetian/Palazzo and Wynn/Encore properties.
2008-12-01 • Las Vegas
A 'GSA Investment & Acquisition Opportunity' being offered for a property.
Date unknown • St Thomas, USVI
Opening of Wyndam Blue Timeshares.
2015-07-01 • Las Vegas
A thorough study of services available to domestic and foreign victims was conducted by the Senior Policy Operating Group.
2005-01-01
St. Croix hosts a Veterans Day parade, starting at 9:30 a.m. at Bassin Triangle and ending at the Christiansted grandstand.
2012-11-12 • St. Croix
A 'GSA Investment & Acquisition Opportunity' being offered by Stan Johnson Company.
Date unknown • St. Thomas, USVI
Proposed construction of a new General Services Administration (GSA) facility to be occupied by the Citizenship and Immigrations Services (CIS).
Date unknown • Smith Bay, St. Thomas, USVI
Offering of a 38.5-acre property for sale via a Confidential Offering Memorandum.
Date unknown • Not specified
Planned construction of a 12,770 SF facility for U.S. Citizenship and Immigration Services, intended as a mission-critical consolidation of CIS offices.
2015-01-01 • St. Thomas, U.S. Virgin Islands
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event